Team:RMIT Australia/Team

From 2010.igem.org

(Difference between revisions)

Revision as of 06:09, 1 July 2010

Who are we???

Instructors:

Philip Poronnik
Leonard Pattenden
Florencia Camus
Emily Guo
Robert Shepherd

Advisors

Paul Jones
Damian D'Souza

Undergraduates:

Symon Smith: Studying biotechnology. I previously studied at Victoria University of Wellington for a semester, including an introductory course to biotechnology which covered the history of biotechnology, including the pharmaceutical industry and bioethics. The possibility of designing artificial living systems inspired me then, as a further step after the development of nutraceuticals and production in vivo of pharmacological products as an alternative to physical and chemical methods. From here I have developed an interest in microbiology, as I learnt more and the possibilities of synthetic biology being applied to population-level behaviour of cells as an area in which I have a personal interest. The idea of moving to an infrastructure that involves less transportation of materials and extractive technologies is one reason I like synthetic biology, also the reduction in cost of research enabling cheaper access to the products of biotechnology.

Ebony Perkins: Studying biotechnology. Other interests include theatre, travelling and animals.

Sebastian Ramov: I have participated in iGEM 2009 and it rocked so i am back here again to rock MIT. I believe that with synthetic biology we can revolutionise the pharmaceutical industry and science in general. i cant wait to graduate to enter the work force.
Jeremy Nagels: Loves patent law :-)
Michelle Chayeb: This is my second year in iGEM and had a great experience from 2009. i am studying pharmaceutical science and am interested in the pharmaceutical industry concerning research and development/design.
Dannii Kamato:

The Story so far

(19 June 2010):

Jeremy Nagels, a student at Monash university, Ebony and Symon have begun discussing various project ideas. These include:

Oscillators

The use of the Hydrogenase 3 complex to generate Hydrogen within E Coli as a form of biofuel.

The possibility of biological prevention of tooth decay with biobricks.

The application of biobricks to a mixed cell community.

The development of cell free transcription/ translation within a cellular system, for example the phloem of a plant, (although the development of this level of symbiosis may be the stuff of future projects)

The attempt is being made to develop a project that in some ways reflects these interests and possibly taps a common thread underlying them.

  (22th June:)

Work has begun on creating primers to extract the protein we are working on from its wild-type plasmid into a plasmid which conforms to biobrick cloning standards.

(29th June):

The group has undertaken PC2 training in readiness for practical lab work.

(30th June): Work is underway on designing primers to put the protein we are working on into an expression peptide, and the team are upskilling themselves to develop the knowledge required for this process.

Where we're from

Florencia Camus: Chile and Queensland. Len Pattenden: England! and Australia.

Symon: New Zealand and Melbourne. Ebony comes from Geelong. Jeremy from Clayton Monash.

@@ Line 426: / Line 426: @@
 ===Undergraduates:===
-*'''Symon Smith''':    Studying biotechnology. Interests outside of science include architecture, music and reading. I hope to one day apply science to the creation of novelty pets, such as tabletop elephants, or glow in the dark cats, while saving the world with synthetic biology.
+*'''Symon Smith''':    Studying biotechnology. I previously studied at Victoria University of Wellington for a semester, including an introductory course to biotechnology which covered the history of biotechnology, including the pharmaceutical industry and bioethics. The possibility of designing artificial living systems inspired me then, as a further step after the development of nutraceuticals and production in vivo of pharmacological products as an alternative to physical and chemical methods. From here I have developed an interest in microbiology, as I learnt more and the possibilities of synthetic biology being applied to population-level behaviour of cells as an area in which I have a personal interest. The idea of moving to an infrastructure that involves less transportation of materials and extractive technologies is one reason I like synthetic biology, also the reduction in cost of research enabling cheaper access to the products of biotechnology.
 *'''Ebony Perkins''': Studying biotechnology. Other interests include theatre, travelling and animals.
-*'''Sebastian Ramov''': i have participated in iGEM 2009 and it rocked so i am back here again to rock MIT. i believe that with synthetic biology we can revolutionise the pharmaceutical industry and science in general. i cant wait to graduate to enter the work force.
+*'''Sebastian Ramov''': I have participated in iGEM 2009 and it rocked so i am back here again to rock MIT. I believe that with synthetic biology we can revolutionise the pharmaceutical industry and science in general. i cant wait to graduate to enter the work force.
 *'''Jeremy Nagels''': Loves patent law :-)
 *'''Michelle Chayeb''': This is my second year in iGEM and had a great experience from 2009. i am studying     pharmaceutical science and am interested in the pharmaceutical industry concerning research and development/design.